Skip to main content
OpenTrials
Completed

NCT Number: NCT01278524

International Multicenter Study One Day Prevalence Observational Study for Delirium on ICU

An anonymous international multicenter - clinical survey, one-day observational study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Delirium Confusion Mental Disorders Nervous System Diseases Neurobehavioral Manifestations Neurocognitive Disorders Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin

Berlin, State of Berlin, 13353, Germany

About this study

Delirium is a serious complication in postoperative and critically ill patients and is independently associated with cognitive impairment at hospital discharge and with significantly higher 6-month mortality. Furthermore, ICU delirium is associated with more days requiring mechanically ventilation, longer ICU length of stay, and longer hospital length of stay. More recently a study by Pisani and co-workers' could show an association between days of delirium and mortality; - each additional day spent in delirium is associated with a 20% increased risk of prolonged hospitalization - translating to over 10 additional days - and a 10% increased risk of death.The reported prevalence of delirium in critically ill patients ranges widely from 11% to 87%. The aim of our study is to investigate the implementation rate of routine delirium assessment in European ICUs.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients staying in the ICU on the 25th of January (one-day prevalence study)

No exclusion Criteria:

Treatment and study plan

Primary outcomes

  1. Implementation rate of routine delirium assessment

    Time frame: 24 hours

Secondary outcomes

  1. Point prevalence of ICU delirium

    Time frame: 24 hours

  2. Methodology of delirium assessment (e.g. type of score, frequency of evaluation)

    Time frame: 24 hours

  3. Non-pharmacological treatment-/prevention strategies

    Time frame: 24 hours

  4. Drugs used for delirium treatment

    Time frame: 24 hours

  5. Sedation practices (e.g. scales, daily sedation goals, SBT - spontaneous breathing trials, SAT - spontaneous awakening trials)

    Time frame: 24 hours

  6. Analgesia regimes (e.g. scales)

    Time frame: 24 hours

Sponsors and collaborators

Lead sponsor

Claudia Spies

Other

Collaborators

  • European Society of Intensive Care Medicine

Registry information

Acronym: IMPROVE-ICU

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Jan 19, 2011
Registry last updated
Aug 13, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.